Literature DB >> 26130644

The Effect of Stress and Depression on Gastrointestinal Diseases.

Cemil Celik1, Barbaros Ozdemir1, Taner Oznur1.   

Abstract

Entities:  

Year:  2015        PMID: 26130644      PMCID: PMC4496894          DOI: 10.5056/jnm15073

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


× No keyword cloud information.
TO THE EDITOR: In a recent issue of the Journal of Neurogastroenterology and Motility, we were very interested in the article by Lee et al1 entitled “The Effect of emotional stress and depression on the prevalence of digestive diseases” in which the investigators reported that stress and depression are related to various digestive diseases and may be predisposing factors for functional dyspepsia and irritable bowel syndrome, and that depression may be a predisposing factor for gastric cancer. This study is well designed but we would like to comment on some of the factors that can affect depression and stress as these may shed new light on the author’s interpretations. Large-scale studies that aim to determine psychological processes such as depression and stress levels in psychosomatic diseases such as gastrointestinal diseases should meticulously consider the risk factors that affect these processes. At the same time, the inclusion and exclusion criteria should be well structured. For example, the main factors that affect stress and depression levels are psychotropic medication and regular exercise. We know that both psychotropic medication2 and regular exercise3 decrease levels of depression and stress. The study by Lee et al1 did not specify whether or not participitants used psychotropic medication or exercised regularly, nor did it specify if these factors were used as exclusion or inclusion criteria. In addition, most women begin to experience emotional changes before and during menstruation period which are known as premenstrual syndrome (PMS).4 Symptoms of PMS include affective, physical, cognitive, and behavioral changes. Affective symptoms include irritability (ie, a cardinal symptom), mood swings, anxiety, and depression.5–6 These psychological symptoms do not only occur during PMS but can also be seen during and after menopause. Upon entering menopause, women may experience a wide range of feelings, from anxiety and discomfort to release and relief.7–8 Thus, stress and depression levels show fluctuations during the menstrual cycle and menopausal period. In this study, the authors did not state the menstrual status of female individuals which could cause unnaturally lower or higher stress and depression levels. We think that it is highly important to examine these issues in order to reliably interpret the study results. Clarifying these 2 concerns will provide a clearer picture when interpreting stress and depression levels among participants.
  8 in total

Review 1.  The effect of exercise on depression, anxiety and other mood states: a review.

Authors:  A Byrne; D G Byrne
Journal:  J Psychosom Res       Date:  1993-09       Impact factor: 3.006

2.  Shu‑Yu capsule, a Traditional Chinese Medicine formulation, attenuates premenstrual syndrome depression induced by chronic stress constraint.

Authors:  Xingxiao Gao; Peng Sun; Mingqi Qiao; Sheng Wei; Ling Xue; Huiyun Zhang
Journal:  Mol Med Rep       Date:  2014-09-26       Impact factor: 2.952

3.  Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Karen A Matthews; Laura L Schott; Sarah Brockwell; Nancy E Avis; Howard M Kravitz; Susan A Everson-Rose; Ellen B Gold; MaryFran Sowers; John F Randolph
Journal:  J Affect Disord       Date:  2007-02-28       Impact factor: 4.839

4.  Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.

Authors:  Lee S Cohen; Claudio N Soares; Allison F Vitonis; Michael W Otto; Bernard L Harlow
Journal:  Arch Gen Psychiatry       Date:  2006-04

Review 5.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 6.  Review article: The rationale for antidepressant therapy in functional gastrointestinal disorders.

Authors:  M Z D Castle; D B A Silk; G W Libby
Journal:  Aliment Pharmacol Ther       Date:  2004-05-01       Impact factor: 8.171

7.  Premenstrual syndrome.

Authors:  Kimberly Ann Yonkers; P M Shaughn O'Brien; Elias Eriksson
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

8.  The effect of emotional stress and depression on the prevalence of digestive diseases.

Authors:  Sang Pyo Lee; In-Kyung Sung; Jeong Hwan Kim; Sun-Young Lee; Hyung Seok Park; Chan Sup Shim
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

  8 in total
  1 in total

1.  The Effect of Stress and Depression on Gastrointestinal Diseases: Author's Reply.

Authors:  Sang Pyo Lee; In Kyung Sung
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.